Kensuke Tateishi

3.6k total citations
69 papers, 1.6k citations indexed

About

Kensuke Tateishi is a scholar working on Genetics, Neurology and Molecular Biology. According to data from OpenAlex, Kensuke Tateishi has authored 69 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Genetics, 20 papers in Neurology and 16 papers in Molecular Biology. Recurrent topics in Kensuke Tateishi's work include Glioma Diagnosis and Treatment (29 papers), Neuropeptides and Animal Physiology (10 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Kensuke Tateishi is often cited by papers focused on Glioma Diagnosis and Treatment (29 papers), Neuropeptides and Animal Physiology (10 papers) and Cancer, Hypoxia, and Metabolism (9 papers). Kensuke Tateishi collaborates with scholars based in Japan, United States and United Kingdom. Kensuke Tateishi's co-authors include Takafumi Hamaoka, E Hashimura, Daniel P. Cahill, Hiroaki Wakimoto, Nobutaka Kawahara, M. Tohyama, Sadao Shiosaka, Koichi Ichimura, Shintaro Fukushima and Yasuji Miyakita and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Journal of Neuroscience.

In The Last Decade

Kensuke Tateishi

65 papers receiving 1.6k citations

Peers

Countries citing papers authored by Kensuke Tateishi

Since Specialization

Citations

This map shows the geographic impact of Kensuke Tateishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kensuke Tateishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kensuke Tateishi more than expected).

Fields of papers citing papers by Kensuke Tateishi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kensuke Tateishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kensuke Tateishi. The network helps show where Kensuke Tateishi may publish in the future.

Co-authorship network of co-authors of Kensuke Tateishi

This figure shows the co-authorship network connecting the top 25 collaborators of Kensuke Tateishi. A scholar is included among the top collaborators of Kensuke Tateishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kensuke Tateishi. Kensuke Tateishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HR eye & MMR eye: one-day assessment of DNA repair-defective tumors eligible for targeted therapy 2025 ·Nature Communications ·(unknown), Shingo Kato, (unknown), (unknown), (unknown), Taichi Mizushima, Kensuke Tateishi, Noritaka Adachi	1
2	Phase I clinical trial of ⁶⁴Cu-ATSM for malignant brain tumors. 2024 ·Journal of Clinical Oncology ·Hiroaki Kurihara, Yoshitaka Narita, Kimiteru Ito, Hidemitsu Sato, Yasuji Miyakita, Masamichi Takahashi, (unknown), Natsuko Okita, Ryo Sadachi, Kensuke Tateishi, Yukie Yoshii, Atsuo Waki, Hiroki Hashimoto, Hisashi Suzuki, Ming‐Rong Zhang, Kazunori Kawamura, Natsuki Honda, Mitsuyoshi Yoshimoto, Hiroki Matsumoto	1
3	Primary intracranial sarcoma associated with DICER1 mutant: a case report and preclinical investigation 2024 ·Brain Tumor Pathology ·(unknown), Kensuke Tateishi, (unknown), (unknown), Shin‐ichi Tsujimoto, Hiroaki Hayashi, (unknown), Yoshiko Nakano, Koichi Ichimura, Shoji Yamanaka, Motohiro Kato, Satoshi Fujii, Shuichi Ito, (unknown), Tetsuya Yamamoto	0
4	Extranodal lymphoma: pathogenesis, diagnosis and treatment 2023 ·Molecular Biomedicine ·Hua Yang, Yang Xun, Chao Ke, Kensuke Tateishi, Hua You	1
5	Development of a contacting transwell co-culture system for the in vitro propagation of primary central nervous system lymphoma 2023 ·Frontiers in Cell and Developmental Biology ·Mayuko Nishi, Kensuke Tateishi, Sundararaj Stanleyraj Jeremiah, Yoko Ino, Yusuke Nakai, (unknown), Yutaro Yamaoka, (unknown), Kei Miyakawa, Hirokazu Kimura, Yayoi Kimura, Tetsuya Yamamoto, Akihide Ryo	1
6	Evaluation of Tumor Cell Infiltration to the Skull in Dermatofibrosarcoma Protuberans of the Scalp: Case Report and Literature Review 2021 ·NMC Case Report Journal ·(unknown), Taishi Nakamura, Akio Miyake, Ikuma Kato, Kensuke Tateishi, Shoji Yamanaka, Tetsuya Yamamoto	3
7	Verbal and memory deficits caused by aphasic status epilepticus after resection of a left temporal lobe glioma 2021 ·Surgical Neurology International ·(unknown), Naoki Ikegaya, Yohei Miyake, Takahiro Hayashi, Hidetoshi Murata, Kensuke Tateishi, Tetsuya Yamamoto	0
8	Poly(ADP-ribose) Glycohydrolase Inhibition Sequesters NAD+ to Potentiate the Metabolic Lethality of Alkylating Chemotherapy in IDH-Mutant Tumor Cells 2020 ·Cancer Discovery ·Hiroaki Nagashima, Christine K. Lee, Kensuke Tateishi, Fumi Higuchi, Megha Subramanian, (unknown), (unknown), Julie J. Miller, Hiroaki Wakimoto, Daniel P. Cahill	43
9	Incision Edge “Lifting Method” in Cerebral Bypass Surgery: A Novel Optional Technique for Narrow or Thin Recipient Arteries 2020 ·World Neurosurgery ·Ryohei Miyazaki, Hidetoshi Murata, Mitsuru Sato, (unknown), Naoki Ikegaya, (unknown), (unknown), (unknown), Nobuyuki Shimizu, Kensuke Tateishi, Jun Suenaga, Tetsuya Yamamoto	2
10	Sirtuin activation targets IDH-mutant tumors 2020 ·Neuro-Oncology ·Julie J. Miller, Alexandria L. Fink, (unknown), Hiroaki Nagashima, Megha Subramanian, Christine K. Lee, (unknown), Shilpa S. Tummala, Kensuke Tateishi, Hiroaki Wakimoto, Daniel P. Cahill	19
11	Human recombinant erythropoietin improves motor function in rats with spinal cord compression-induced cervical myelopathy 2019 ·PLoS ONE ·Takahiro Tanaka, Hidetoshi Murata, Ryohei Miyazaki, Tetsuya Yoshizumi, Mitsuru Sato, Makoto Ohtake, Kensuke Tateishi, Phyo Kim, Tetsuya Yamamoto	3
12	Prognostic implications of 62Cu-diacetyl-bis (N4-methylthiosemicarbazone) PET/CT in patients with glioma 2018 ·Annals of Nuclear Medicine ·Akira Toriihara, Makoto Ohtake, Kensuke Tateishi, (unknown), (unknown), Yoshio Kitazume, Tomio Inoue, Nobutaka Kawahara, Ukihide Tateishi	15
13	Succinate Dehydrogenase B Subunit–Negative Jugular Foramen Paraganglioma Manifesting Malignant Progression with Pseudohypoxia-Related Atypical Uptake of [ 18 F]-Fluoro-2-Deoxy- d -Glucose: A Case Report 2018 ·World Neurosurgery ·Makoto Ohtake, Kensuke Tateishi, Hidetoshi Murata, Yoji Nagashima, Shoji Yamanaka, Tetsuya Yamamoto	3
14	The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in IDH1 -Mutant Cancers and Potentiates NAD+ Depletion–Mediated Cytotoxicity 2017 ·Cancer Research ·Kensuke Tateishi, Fumi Higuchi, Julie J. Miller, Mara V.A. Koerner, Nina Lelic, Ganesh M. Shankar, Shota Tanaka, David E. Fisher, Tracy T. Batchelor, A. John Iafrate, Hiroaki Wakimoto, S. Andrew, Daniel P. Cahill	73
15	Encouraging option of multi-staged gross total resection for a C11orf-RelA fusion-positive supratentorial anaplastic ependymoma 2017 ·Brain Tumor Pathology ·Taishi Nakamura, Kohei Fukuoka, (unknown), (unknown), Naoko Udaka, Reo Tanoshima, Kensuke Tateishi, Shoji Yamanaka, Koichi Ichimura, Tetsuya Yamamoto	7
16	Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma 2016 ·Clinical Cancer Research ·Kensuke Tateishi, A. John Iafrate, Quan Ho, William T. Curry, Tracy T. Batchelor, Keith T. Flaherty, Maristela L. Onozato, Nina Lelic, (unknown), Daniel P. Cahill, S. Andrew, Hiroaki Wakimoto	119
17	Characteristics and surgical strategies for posterior clinoid process meningioma: two case reports and review of the literature 2016 ·Neurosurgical Review ·Hajime Takase, (unknown), Kensuke Tateishi, Takaakira Yokoyama, Hidetoshi Murata, Nobutaka Kawahara	9
18	Targetable Signaling Pathway Mutations Are Associated with Malignant Phenotype in IDH -Mutant Gliomas 2014 ·Clinical Cancer Research ·Hiroaki Wakimoto, Shota Tanaka, William T. Curry, Franziska Loebel, Dan Zhao, Kensuke Tateishi, Juxiang Chen, (unknown), Nina Lelic, James C. Kim, Dora Dias‐Santagata, Leif W. Ellisen, Darrell R. Borger, Sarah‐Maria Fendt, Matthew G. Vander Heiden, Tracy T. Batchelor, A. John Iafrate, Daniel P. Cahill, S. Andrew	130
19	Occipitocervical fusion with relief of odontoid invagination: atlantoaxial distraction method using cylindrical titanium cage for basilar invagination—case report 2014 ·Neurosurgical Review ·Tetsuya Yoshizumi, Hidetoshi Murata, (unknown), Mitsuru Sato, Hajime Takase, Kensuke Tateishi, (unknown), Jun Suenaga, Nobutaka Kawahara	17
20	62Cu-Diacetyl-Bis (N4-Methylthiosemicarbazone) PET in Human Gliomas: Comparative Study with [18F]Fluorodeoxyglucose and L-Methyl-[11C]Methionine PET 2013 ·American Journal of Neuroradiology ·Kensuke Tateishi, Ukihide Tateishi, (unknown), Makoto Ohtake, Ryogo Minamimoto, Jun Suenaga, Hiroto Murata, Kazuo Kubota, Tomio Inoue, N. Kawahara	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact